National Bank Of Canada Biogen Inc. Transaction History

National Bank Of Canada

$62.9 Billion
Q2 2024

A detailed history of National Bank Of Canada transactions in Biogen Inc. stock. As of the latest transaction made, National Bank Of Canada holds 54,304 shares of BIIB stock, worth $9.44 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

54,304

Previous 72,824 25.43%

Holding current value

$9.44 Million

Previous $15.7 Million 19.84%

% of portfolio

0.02%

Previous 0.03%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$190.52 - $236.72 $3.53 Million - $4.38 Million	-18,520 Reduced 25.43%	54,304 $12.6 Million
Q1 2024 May 13, 2024	SELL	$212.02 - $267.71 $27.2 Million - $34.4 Million	-128,451 Reduced 63.82%	72,824 $15.7 Million
Q4 2023 Feb 06, 2024	BUY	$222.59 - $267.94 $18.8 Million - $22.6 Million	84,284 Added 72.04%	201,275 $52.1 Million
Q3 2023 Oct 10, 2023	BUY	$253.3 - $285.89 $17.3 Million - $19.5 Million	68,282 Added 140.18%	116,991 $30.1 Million
Q2 2023 Jul 26, 2023	BUY	$275.25 - $318.06 $9.63 Million - $11.1 Million	34,971 Added 254.56%	48,709 $13.9 Million
Q1 2023 Apr 12, 2023	SELL	$256.56 - $292.34 $2.39 Million - $2.73 Million	-9,333 Reduced 40.45%	13,738 $3.82 Million
Q4 2022 Jan 24, 2023	SELL	$252.44 - $306.72 $865,869 - $1.05 Million	-3,430 Reduced 12.94%	23,071 $0
Q3 2022 Oct 13, 2022	SELL	$194.69 - $268.46 $241,999 - $333,695	-1,243 Reduced 4.48%	26,501 $7.01 Million
Q2 2022 Jul 28, 2022	SELL	$187.54 - $223.02 $15,378 - $18,287	-82 Reduced 0.29%	27,744 $5.84 Million
Q1 2022 May 05, 2022	BUY	$193.77 - $244.14 $4.62 Million - $5.82 Million	23,844 Added 598.79%	27,826 $6.11 Million
Q4 2021 Jan 24, 2022	BUY	$223.92 - $287.77 $891,649 - $1.15 Million	3,982 New	3,982 $960,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.

Account

National Bank Of Canada Biogen Inc. Transaction History